Pharmacotherapy of constipation in children

Therapy

Volumn 1, Issue 1, 2004, Pages 149-157

  Pashankar, Dinesh S ^a   Tolia, Vasundhara ^b  

^a UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^b CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Constipation; Encopresis; Infant dyschezia

Indexed keywords

ANTACID AGENT; ANTIDEPRESSANT AGENT; BISACODYL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; COLCHICINE; COLESTYRAMINE; ERYTHROMYCIN; GLYCEROL; IRON; ISPAGULA; LACTULOSE; LAXATIVE; MACROGOL 3350; MAGNESIUM CITRATE; MAGNESIUM HYDROXIDE; MANNAN; METHYLCELLULOSE; METOCLOPRAMIDE; MILK PROTEIN; MINERAL OIL; MISOPROSTOL; MOLASSES; OPIATE DERIVATIVE; PRUCALOPRIDE; SENNA EXTRACT; SODIUM CHLORIDE; SORBITOL; TEGASEROD; UNINDEXED DRUG;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ANUS DISEASE; ASPIRATION PNEUMONIA; BEHAVIOR MODIFICATION; BLOATING; CARDIOPULMONARY INSUFFICIENCY; CHILD; CHILD CARE; CLINICAL EXAMINATION; CLINICAL TRIAL; COMA; CONSTIPATION; CONVULSION; DIARRHEA; DIET THERAPY; DRUG ABSORPTION; DRUG COST; DRUG FATALITY; ECG ABNORMALITY; ELECTROLYTE DISTURBANCE; FAMILY; FECES IMPACTION; FECES INCONTINENCE; FLATULENCE; FLUID THERAPY; HEALTH CARE DELIVERY; HEALTH EDUCATION; HEART ARRHYTHMIA; HEPATITIS; HUMAN; HYPERMAGNESEMIA; HYPERNATREMIA; HYPERPHOSPHATEMIA; HYPERTROPHIC OSTEOARTHROPATHY; HYPOCALCEMIA; HYPOKALEMIA; HYPOPHOSPHATEMIA; KIDNEY DISEASE; LIVER DYSFUNCTION; LONG TERM CARE; MAINTENANCE THERAPY; MELANOSIS; NAUSEA; PARENT; PATHOGENESIS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PSYCHOTRAUMA; QT PROLONGATION; RESPIRATION DEPRESSION; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING; UROLITHIASIS; VOMITING;

EID: 14544270306     PISSN: 14750708     EISSN: None     Source Type: Journal    
DOI: 10.1586/14750708.1.1.149     Document Type: Review

References (50)

1. Issenman, Hewson S, Pirhonen D, Taylor, Tirosh A. Are chronic digestive complaints the result of abnormal dietary patterns. Am. J. Dis. Child. 141, 679-682 (1987).
2. De Araujo Sant'Anna AMG, Calcado AC: Constipation in school-aged children at public schools in Rio de Janeiro, Brazil. J. Pediatr. Gastroenterol. Nutr. 29, 190-193 (1999).
3. Loening-Baucke V: Chronic constipation in children. Gastroenterology 105, 1557-1564 (1993).
4. Rasquin-Weber A, Hyman PE, Cucchiara S et al.: Childhood functional gastrointestinal disorders. Gut 45, 1160-1168 (1999).
5. Baker SS, Liptak GS, Colletti RB et al.: Constipation in infants and children: evaluation and treatment. J. Pediatr. Gastroenterol. Nutr. 29, 612-626 (1999).
6. Staiano A, Andreotti MR, Greco L, Basile P, Auricchio S: Long-term follow-up of children with chronic idiopathic constipation. Dig. Dis. Sci. 39, 561-564 (1994).
7. Herek O, Polat A: Incidence of anterior displacement of the anus and its relationship to constipation in children. Surg. Today 34, 190-192 (2004)
8. Gold DM, Levine J, Weinstein TA, Kessler BH, Pattei MJ: Frequency of digital rectal examination in children with chronic constipation. Arch. Pediatr. Adol. Med. 153, 377-379 (1999).
9. Leech SC, McHugh K, Sullivan PB: Evaluation of a method of assessing fecal loading on plain abdominal radiographs in children. Pediatr. Radiol. 29, 255-258 (1999).
10. Williams CL, Bollella M, Wynder EL: A new recommendation for dietary fiber in childhood. Pediatrics 96, 985-988 (1995).
11. Iacono G, Cavataio F, Montalto G et al.: Intolerance of cow's milk and chronic constipation in children. N. Engl J. Med. 339, 1100-1104 (1998).
12. Nolan T, Debelle G, Oberklaid et al.: Randomized trial of laxatives in treatment of childhood encopresis. Lancet 338, 523-527 (1991).
13. Roma E, Adamidis D, Nikolara R et al.: Diet and chronic constipation in children: the role of fiber. J. Ped. Gastroenterol. Nutr. 28, 169-174 (1999).
14. Staiano A, Simeone D, Del Giudice E et al.: Effect of the dietary fiber glucomannan on chronic constipation in neurologically impaired children. J. Pediatr. 136, 41-45 (2000).
15. Loaning-Baucke V, Miele E, Staiano A: Fiber (Glucomannan) is beneficial in the treatment of childhood constipation. Pediatrics 113, E259-E264 (2004).
16. Gattuso JM, Kamm MA: Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Saf. 10, 47-65 (1994).
17. Loening-Baucke V: Constipation in early childhood: patient characteristics, treatment and long-term follow-up. Gut 34, 400-404 (1993).
18. McLaughlin SA, McKinney PE: Antacid-induced hypermagnesemia in a patient with normal renal function and bowel obstruction. Ann. Pharmacother. 32, 312-315 (1998).
19. Van Ginkel R, Reitsma JB, Buller HA et al.: Childhood constipation: longitudinal follow-up beyond puberty. Gastroenterology 125, 357-363 (2003).
20. Tolia V, Lin CH, Elitsur Y: A prospective randomized study with mineral oil and oral lavage solution for treatment of fecal impaction in children. Aliment. Pharmacol. Ther. 7, 523-529 (1993).
21. Sharif F, Crushell E, O'Driscoll K, Bourke B: Liquid paraffin: a reappraisal of its role in the treatment of constipation. Arch. Dis. Child. 85, 121-125 (2001).
22. Clark JH, Russell GJ, Fitzgerald JF, Nagamori KE: Serum β-carotene, retinal and α-tocopherol levels during mineral oil therapy for constipation. Am. J. Dis. Child. 141, 1210-1212 (1987).
23. Dahshan A, Lin C, Peters J, Thomas R, Tolia V: A randomized, prospective study to evaluate the efficacy and acceptance of three bowel preparations for colonoscopy in children. Am. J. Gastroenterol. 94, 3497-3501 (1999).
24. DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB: A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethyleneglycol laxative. Am J. Gastroenterol. 95, 446-449 (2000).
25. Brady CE, DiPalma JA, Morawski SG, Sanata Ana CA, Fordtran JS: Urinary excretion of polyethyleneglycol 3350 and sulfate after gut lavage with a polyethyleneglycol electrolytc lavage solution. Gastroenterology 90, 1914-1918 (1986).
26. DiPiro JT, Michael KA, Clark BA et al.: Absorption of polyethyleneglycol after administration of a PEG-dectrolyte lavage solution. Clin. Pharm. 5, 153-155 (1986).
27. Pashankar DS, Bishop WP: Efficacy and optimal dose of daily polyethyleneglycol 3350 for treatment of constipation and encopresis in children. J. Pediatr. 139, 428-432 (2001).
28. Youssef NN, Peters JM, Henderson W et al.: Dose response of PEG 3350 for the treatment of childhood fecal impaction. J. Pediatr. 141, 410-414 (2002).
29. Pashankar DS, Bishop WP, Loening-Baucke V: Long-term efficacy of polyethyleneglycol 3350 for the treatment of chronic constipation in children with and without encopresis. Clin Pediatr. 42, 815-819 (2003).
30. Pashankar DS, Loening-Baucke V, Bishop W: Safety of polyethyleneglycol 3350 for the treatment of chronic constipation in children. Arch. Pediatr. Adolesc. Med. 157, 661-664 (2003).
31. Pashankar DS, Loening-Baucke V, Krishna R, Comstock J: Polyethyleneglycol 3350 for the treatment of constipation in children under the age of 2 years. Gastroenterology 126, 218-219 (2004).
32. Gremse DA, Hixon J, Crutchfield A: Comparison of polyethyleneglycol 3350 and lactulose for treatment of chronic constipation in children. Clin. Pediatr. 41, 225-229 (2002).
33. Loening-Baucke V: Polyethyleneglycol without electrolytes for children with constipation and encopresis. J. Pediatr. Gastroenterol. Nutr. 34, 372-377 (2002).
34. Ismail EAR, Al-Mutairi G, Al-Anzy H: A fatal small dose of phosphate enema in a young child with no renal or gastrointestinal abnormality. J. Pediatr. Gastroenterol. Nutr. 30, 220-221 (2000).
35. Walker M, Warner BW, Brilli RJ, Jacobs BR: Cardiopulmonary compromise associated with milk and molasses enema use in children. J. Pediatr. Gastroenterol. Nutr. 36, 144-148 (2003).
36. Nurko S, Garcia-Aranda JA, Worona LB, Zlochisty O: Cisapride for the treatment of constipation in children: a double-blind study. J. Pediatr. 136, 35-40 (2000).
37. Staiano A, Cucchiara S, Andreotti MR, Minella R, Manzi G: Effect of ciaspride on chronic idiopathic constipation in children. Dig. Dis. Sci. 36, 733-736 (1991).
38. Halabi IM: Cisapride in management of chronic pediatric constipation. J. Pediatr. Gastroenterol. Nutr. 28, 199-202 (1999).
39. Odeka EB, Sagher F, Miller V, Doig C: Use of cisapride in treatment of constipation in children. J. Pediatr. Gastroenterol. Nutr. 25, 199-203 (1997).
40. Khongphatthanayothin A, Lane J, Thomas D et al.: Effects of cispride on QT interval in children. J. Pediatr. 133, 51-56 (1998).
41. Enger C, Cali C, Walker AM: Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States. Pharmacoepidemiol. Drug Saf. 11, 477-486 (2002).
42. Bellomo-Brandao MA, Collares EF, DaCosta-Pinto EAL: Use of erythromycin for the treatment of severe chronic constipation in children. Braz. J. Med. Biol. Res. 36, 1391-1396 (2003).
43. Loening-Baucke V: Encopresis. Curr. Opin. Pediatr. 14, 570-575 (2002).
44. Grider JR, Foxx-Orenstein AE, Jin JG: 5-hydroxytryptamine-4 receptor agonists initiate the peristaltic reflex in human, rat and guinea-pig intestine. Gastroenterology 115, 370-380 (1998).
45. Müller-Lissner SA, Fumagalli I, Bardhan KD et al.: Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol. Ther. 15, 1655-1666 (2001).
46. Rivkin A: Tegaserod maleate in the treatment of irritable bowel syndrome: a clinical review. Clin. Ther. 25, 1952-1974 (2003).
47. Sloots CE, Poen AC, Kerstens R et al.: Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation. Aliment. Pharmacol. Ther. 16, 759-767 (2002).
48. Coremans G, Kerstens R, De Pauw M, Stevens M: Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial. Digestion 67, 82-89 (2003).
49. Roarty TP, Weber F, Soykan I et al.: Misoprostol in the treatment of chronic refractory constipation: results of a long-term open label trial. Aliment. Pharmacol. Ther. 11, 1059-1066 (1997).
50. Verne GN, Davis RH, Robinson ME et al.: Treatment of chronic constipation with colchicine; randomized, double-blind, placebo-controlled crossover trial. Am. J. Gastroenterol. 98, 1112-1116 (2003).